Diabetic ketoacidosis associated with aripiprazole

Diabetic Medicine

Volumn 22, Issue 10, 2005, Pages 1440-1443

  Church, Chelsea O ^a   Stevens, D L ^b   Fugate, S E ^b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Aripiprazole; Atypical antipsychotics; Diabetic ketoacidosis; Hyperglycaemia; Olanzapine

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; INSULIN; ISOPHANE INSULIN; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC ACIDOSIS; PRESCRIPTION; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN, ISOPHANE; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 25844432898     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01628.x     Document Type: Article

References (30)

1. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004; 27: 596-601.
2. Warning about hyperglycemia and atypical antipsychotic drugs, 2004: Available from http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/psn/printer. cfm?id=229. [Accessed 22 July 2004.]
3. Koval MS, Rames LJ, Christie S. Diabetic ketoacidosis associated with clozapine treatment. Am J Psychiatry 1994; 151: 1520-1.
4. Kostakoglu AE, Yazici KM, Erbas T, Guvener N. Ketoacidosis as a side effect of clozapine: a case report. Acta Psychiatr Scand 1996; 93: 217-8.
5. Peterson GA, Byrd SL. Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 1996; 153: 737-8.
6. Popli AP, Konicki PE, Jurjus GJ, Fuller MA, Jaskiw GE. Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997; 58: 108-11.
7. Ai D, Roper TA, Riley JA. Diabetic ketoacidosis and clozapine. Postgrad Med J 1998; 74: 493-4.
8. Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998; 44: 778-83.
9. Colli A, Cocciolo M, Francobandiera G, Rogantin F, Cattalini N. Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care 1999; 22: 176-7.
10. Maule S, Giannella R, Lanzio M, Villari V. Diabetic ketoacidosis with clozapine treatment. Diabetes Nutr Metab 1999; 12: 187-8.
11. Smith H, Kenney-Herbert J, Knowles L. Clozapine-induced diabetic ketoacidosis. Aust N Z J Psychiatry 1999; 33: 120-1.
12. Avram AM, Patel V, Taylor JP, Kirwan JP, Kalhan S. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis. Ann Pharmacother 2001; 35: 1381-7.
13. Nicolai J, Smith SJ, Keunen RWM. Simultaneous side effects of both clozapine and valproate. Intensive Care Med 2001; 27: 943.
14. Lafayette JM, Pirl WF, Henderson DC. Low-dose clozapine and diabetic ketoacidosis. Psychosomatics 2003; 44: 249-52.
15. Wilson D, D'Souza L, Sarkar N, Newton M, Hammond C. New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophr Res 2003; 59: 1-6.
16. Gatta B, Rigalleau V, Gin H. Diabetic ketoacidosis with olanzapine treatment. Diabetes Care 1999; 22: 1002-3.
17. Goldstein LE, Sporn J, Brown S, Kim H, Finkelstein J, Gaffey GK, Sachs G, Stern TA. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics 1999; 40: 438-43.
18. Lindenmayer JP, Patel R. Olanzapine-induced ketoacidosis with diabetes mellitus. Am J Psychiatry 1999; 156: 1471.
19. Muench J, Carey M. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature. J Am Board Fam Pract 2001; 14: 278-82.
20. Ragucci KR, Wells BJ. Olanzapine-induced diabetic ketoacidosis. Ann Pharmacother 2001; 35: 1556-8.
21. Selva KA, Scott SM. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatr 2001; 138: 936-8.
22. Straker D, Mendelowitz A, Karlin L. Near fatal ketoacidosis with olanzapine treatment. Psychosomatics 2002; 43: 339-40.
23. Waldman J, Yaren S. Atypical antipsychotics and glycemia: a case report. Can J Psychiatry 2002; 47: 686-7.
24. Tavakoli SA, Arguisola MS. Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine. South Med J 2003; 96: 729-30.
25. Torrey EF, Swalwell CI. Fatal olanzapine-induced ketoacidosis. Am J Psychiatry 2003; 160: 2241.
26. Tsuchiyama NH, Ando T, Ota MS, Sakurai M, Takamura T. Modulating effects of olanzapine on the development of diabetic ketoacidosis. Diabet Med 2003; 21: 297-301.
27. Croarkin PE, Jacobs K, Bain BK. Diabetic ketoacidosis associated with risperidone treatment? Psychosomatics 2000; 41: 369-70.
28. Koller EA, Cross JT, Schneider B. Risperidone-associated diabetes mellitus in children. Pediatrics 2004; 113: 421.
29. Koller EA, Doraiswamy PM. Olanzapine-associated diabetes mellitus. Pharmacotherapy 2002; 22: 841-52.
30. Sneed KB, Gonzalez EC. Type 2 diabetes mellitus induced by an atypical antipsychotic medication. J Am Board Fam Pract 2003; 16: 251-4.